Evidence map›Paper›PMID 36501027›Full record

ArticleNutrients2022

A Hydrodistillate of

Minhyeok Song, Minseok Kim, Dang Hieu Hoang, Lochana Mangesh Kovale, Jihyun Lee, Youngjoo Kim, Changhyun Lee, Jongki Hong, Sungchul Park, Wonchae Choe and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Therapeutic Potential ofNutrients · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Exploring the Anti-Inflammatory Activity of the Heat-ProcessedInternational journal of molecular sciences · 2025
    Article
  6. Nutrients · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Minhyeok SongDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Minseok KimDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.ORCID 0000-0002-9717-7165
Dang Hieu HoangDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Lochana Mangesh KovaleDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Jihyun LeeEasy Hydrogen Corporation, Jeju City 63196, Republic of Korea.
Youngjoo KimDepartment of Urology, College of Medicine, Jeju National University, Jeju City 63243, Republic of Korea.ORCID 0000-0001-5580-4338
Changhyun LeeChunjieh Cooperation, Jeju City 63359, Republic of Korea.
Jongki HongCollege of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.ORCID 0000-0001-7742-5232
Sungchul ParkCollege of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.
Wonchae ChoeDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.ORCID 0000-0001-5764-9482
Insug KangDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.ORCID 0000-0001-7117-1008
Sung Soo KimDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Joohun HaDepartment of Biochemistry and Molecular Biology, Graduate School, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Kyung Hee University · KRJeju National University · KR

Funding

National Research Foundation of Korea 2018R1A6A1A03025124National Research Foundation of Korea 2020R1F1A1049980
6 · The paper itself

Abstract

The clinical application of cisplatin, one of the most effective chemotherapeutic agents used to treat various cancers, has been limited by the risk of adverse effects, notably nephrotoxicity. Despite intensive research for decades, there are no effective approaches for alleviating cisplatin nephrotoxicity. This study aimed to investigate the protective effects and potential mechanisms of a Gynostemma pentaphyllum leaves hydrodistillate (GPHD) and its major component, damulin B, against cisplatin-induced nephrotoxicity in vitro and in vivo. A hydro-distillation method can extract large amounts of components within a short period of time using non-toxic, environmentally friendly solvent. We found that the levels of AMP-activated protein kinase α1 (AMPKα1), reactive oxygen species (ROS), and apoptosis were tightly associated with each other in HEK293 cells treated with cisplatin. We demonstrated that AMPKα1 acted as an anti-oxidant factor and that ROS generated by cisplatin suppressed the expression of AMPKα1 at the transcriptional level, thereby resulting in induction of apoptosis. Treatment with GPHD or damulin B effectively prevented cisplatin-induced apoptosis of HEK293 cells and cisplatin-induced acute kidney injury in mice by suppressing oxidative stress and maintaining AMPKα1 levels. Therefore, our study suggests that GPHD and damulin B may serve as prospective adjuvant agents against cisplatin-induced nephrotoxicity.

Indexed as

CisplatinGynostemmaAnimalsApoptosisHEK293 CellsHumansKidneyMiceOxidative StressReactive Oxygen SpeciesCisplatinReactive Oxygen SpeciesAMPKα1cisplatindamulin BGynostemma pentaphyllumnephrotoxicity

Identifiers

PMID36501027
PMCPMC9737728
OpenAlexW4309935808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.